Medication Therapy Management (MTM) for the Patient with Respiratory Disease

In this multi-layered, knowledge/application/practice-based continuing pharmacy education activity the University of Connecticut and Drug Topics will develop pharmacist competence in MTM and Motivational Interviewing.  The activity is designed to expand from knowledge-based activities to practice-based skills by properly scaffolding knowledge, application and practice-based learning opportunities with sound instructional design.

The activities will consist of 3 phases designed to build upon each other to provide comprehensive education in the area of respiratory disease care.  Pharmacists may participate at any level of education that meets their needs, however, a Practice-based Certificate of Achievement will be awarded to those who have completed all phases of the education.

                                                      NEXT LIVE MEETING:                                                     

Thursday, March 29, 2018
The Aqua Turf Club
Mulberry Street
Plantsville, CT
7:30 am – 5:00 pm

REGISTRATION will be up in 2018!

Target Audience:

Pharmacists in all areas of practice who wish to further their clinical and communication skills in the management of patients with respiratory disease to improve respiratory disease management and empower patients with respiratory disease to improve their health

This activity is not accredited for technicians

Learning objectives:

At the conclusion of the practice-based activities – Live event on October 22, 2016, and the the post activity requirements, pharmacists will be able to:

MTM for the Patient with Respiratory Disease  – 15 hours, 1.5 CEU’s
ACPE #0009-9999-16-024-B01-P

Medication Therapy Management for the Patient with Respiratory Disease – Live Meeting

Communication Skills Development for Health Behavior Change in Respiratory Disease Management – 2 hours

  • Identify how motivational interviewing differs from our everyday mode of persuading/motivating patients.
  • Describe the MI communication “tools” that can be used to explore patient resistance and ambivalence.
  • Apply motivational interviewing skills in small group written activities for a respiratory disease management conversation with a non-adherent patient.
  • Apply MI skills in small group role-play activities for case scenario exercises regarding comprehensive respiratory disease management and health behavior change.

Respiratory Disease Management Guidelines and Medication Update – 1 hour

  • Describe the changes to the management of respiratory diseases recommended by major U.S.-based guidelines
  • Discuss new and emerging therapies for respiratory diseases
  • Discuss the place in therapy of recently approved medications for respiratory disease

Drug Delivery in Respiratory Disease – 1 hour

  • Demonstrate proper inhaler technique for all types of inhalers and nebulizers
  • Demonstrate the teach-back method to assess patient inhaler use
  • Recognize the need to routinely assess inhaled medication delivery for patients of every age

Application of MTM Concepts to the Patient with Respiratory Disease – Case Discussion – 4 hours

  • Perform a medication therapy review for a patient with respiratory disease
  • Create a personal medication record
  • Create a patient medication-related action plan
  • Identify medication-related issues that require intervention on the part of the pharmacist to the provider
  • Document the MTM encounter

Post Live Event Patient Interviews – 7 hours

  • Perform initial MTM encounters with 3 patients
  • Perform follow up MTM encounters with 3 patients
  • Complete and submit documentation of patient encounters

Following the live meeting event, pharmacists will be required to perform 3 different patient medication therapy management encounters and document the outcomes of the encounters with a follow up visit 3 months after the initial visit.  Encounter information, with de-identified patient information will be submitted to UConn for verification of certificate requirements and outcomes analysis.

Activity Faculty:

Devra Dang, PharmD, BCPS, CDE, Associate Clinical Professor
School of Pharmacy, University of Connecticut, Storrs, CT

Marissa Salvo, PharmD, Assistant Clinical Professor
School of Pharmacy, University of Connecticut, Storrs, CT

Diana Sobieraj Pharm.D., Assistant Professor of Pharmacy Practice
School of Pharmacy, University of Connecticut, Storrs, CT

Faculty Disclosure:

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

Doctors Dang,   Salvo, and Sobieraj have no actual or potential conflicts of interest associated with this presentation.

Program Fees:

There is a $199 fee for this program.  Parking is complimentary at the Aqua Turf.

Grant Funding: 

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc

ACPE logoThe University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  A practice-based certificate of achievement will be awarded following successful completion of all requirements. MTM for the Patient with Respiratory Disease  – 15 hours, 1.5 CEU’s
ACPE #0009-9999-16-024-B01-P

Online Activities Initial release date:  April 20, 2015
Online Activities Expiration Date:  April 20, 2017
Live Initial Release Date: April 7, 2016
Live Expiration Date:  April 7, 2019

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.